Clinical Trials in Colorado

Showing 6981-7000 of 18,143 trials

Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)

NCT04296864

This is a multi-center, double-masked, randomized, placebo-controlled, parallel-group, efficacy, safety, and tolerability study evaluating the efficacy of Dupilumab in the treatment of signs and symptoms of atopic keratoconjunctivitis (AKC).

Atopic Keratoconjunctivitis

Andover Eye Associates42 participantsStarted Feb 2020

Los Angeles, California, United States • Littleton, Colorado, United States • Hollywood, Florida, United States +17 more locations

TERMINATEDPhase 150 miles

Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma

NCT04609579

This clinical trial is evaluating a drug called SNX281 given by itself and in combination with pembrolizumab (KEYTRUDA®) in participants with advanced solid tumors and lymphoma. The main goals of this study are to: * Find the recommended dose of SNX281 that can be given to participants safely alone and in combination with pembrolizumab (KEYTRUDA®). * Learn more about the side effects and safety profile of SNX281 alone and in combination with pembrolizumab (KEYTRUDA®) * Learn more about pharmacological characteristics of SNX281 alone and in combination with pembrolizumab (KEYTRUDA®) * Learn more about effectiveness of SNX281 alone and in combination with pembrolizumab (KEYTRUDA®)

Advanced Solid TumorAdvanced Lymphoma

Stingthera, Inc.27 participantsStarted Nov 2020

Denver, Colorado, United States • Sarasota, Florida, United States • Philadelphia, Pennsylvania, United States +1 more locations

Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)

Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma

Find Trials by Condition in Colorado

REACH VET Implementation Program Evaluation

Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis

Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas

Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee

Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe Asthma

A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors

A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers

A Study of Melphalan Flufenamide (Melflufen)-Dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide

Study to Evaluate a Procedure for Intra-articular Injection of FX006 in Patients With Osteoarthritis of the Hip

Optimizing Video Communication Assessment for Teaching Error Disclosure Skills

Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial)

Study Evaluating the Treatment of OTX-TKI for Subjects With Neovascular Age-related Macular Degeneration

Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML)

Study to Compare Exposure of TA Following Administration of FX006 or TAcs in Patients With OA of the Shoulder or Hip

Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer

Study to Compare Exposure of TA Following Administration of Either FX006 or TAcs in Patients With Bilateral Knee OA